These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 37805491)

  • 21. Exosomes and cancer: from molecular mechanisms to clinical applications.
    Jafari A; Babajani A; Abdollahpour-Alitappeh M; Ahmadi N; Rezaei-Tavirani M
    Med Oncol; 2021 Mar; 38(4):45. PubMed ID: 33743101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion.
    Yan L; Wang P; Fang W; Liang C
    Cell Biochem Funct; 2020 Apr; 38(3):257-265. PubMed ID: 31749189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
    Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
    Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research progress of exosomes as drug carriers in cancer and inflammation.
    Feng Q; Zhang Y; Fang Y; Kong X; He Z; Ji J; Yang X; Zhai G
    J Drug Target; 2023 Apr; 31(4):335-353. PubMed ID: 36543743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
    Srinivas L; S D; Kgk D; Malla RR
    Crit Rev Oncog; 2019; 24(2):179-190. PubMed ID: 31679212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment.
    Song Q; Yu H; Cheng Y; Han J; Li K; Zhuang J; Lv Q; Yang X; Yang H
    J Transl Med; 2022 Jul; 20(1):308. PubMed ID: 35794606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of exosome-based cell-free strategies to enhance endogenous cell functions in tissue regeneration.
    Deng S; Cao H; Cui X; Fan Y; Wang Q; Zhang X
    Acta Biomater; 2023 Nov; 171():68-84. PubMed ID: 37730080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives.
    Liu Q; Li S; Dupuy A; Mai HL; Sailliet N; Logé C; Robert JH; Brouard S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
    Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
    Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges.
    Kibria G; Ramos EK; Wan Y; Gius DR; Liu H
    Mol Pharm; 2018 Sep; 15(9):3625-3633. PubMed ID: 29771531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.
    Song Y; Kim Y; Ha S; Sheller-Miller S; Yoo J; Choi C; Park CH
    Am J Reprod Immunol; 2021 Feb; 85(2):e13329. PubMed ID: 32846024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The exosome journey: from biogenesis to uptake and intracellular signalling.
    Gurung S; Perocheau D; Touramanidou L; Baruteau J
    Cell Commun Signal; 2021 Apr; 19(1):47. PubMed ID: 33892745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
    Chen C; Shang A; Sun Z; Gao Y; Huang J; Ping Y; Chang W; Gu C; Sun J; Ji P; Yuan Y; Lu R; Li D
    J Immunol Res; 2022; 2022():9038808. PubMed ID: 35127956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Function and therapeutic development of exosomes for cancer therapy.
    Kim SB
    Arch Pharm Res; 2022 May; 45(5):295-308. PubMed ID: 35604532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prospects and challenges of exosomes as drug delivery systems].
    Meng W; Li L; Zhu G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Aug; 37(4):714-720. PubMed ID: 32840090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of plant-derived exosome-like nanoparticles in drug delivery.
    Barzin M; Bagheri AM; Ohadi M; Abhaji AM; Salarpour S; Dehghannoudeh G
    Pharm Dev Technol; 2023 Jun; 28(5):383-402. PubMed ID: 37086283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.